WOBURN, Mass.--(BUSINESS WIRE)--Aphios Corporation today announced receipt of a Phase I Small Business Innovative Research (SBIR) grant from the National Institute on Drug Abuse (NIDA) to develop an improved oral formulation of ?9-THC for marijuana addiction and unmet medical needs.
